Professor Hu Shengshou: Coronary and Complex Cardiac Surgery Specialist
Professor Hu Shengshou is a senior cardiovascular surgeon, professor, doctoral supervisor, and academician of the Chinese Academy of Engineering at Fuwai Hospital and the National Center for Cardiovascular Diseases in Beijing. He is known for clinical leadership in cardiovascular surgery and research into coronary disease, heart failure, myocardial protection, and cardiac regeneration.
His work spans coronary artery bypass surgery, complex adult cardiac surgery, cardiovascular outcomes research, tissue engineering, and translational approaches intended to improve recovery after heart injury.
International patients can learn more about the hospital, required cardiac records, and care planning in our Fuwai Hospital international patient guide.
Clinical and Academic Focus
Professor Hu’s principal areas include:
- coronary artery disease requiring surgical assessment;
- coronary artery bypass grafting;
- complex adult cardiovascular surgery;
- ischemic heart disease and myocardial protection;
- heart failure and ventricular dysfunction;
- outcomes and quality improvement in cardiac surgery;
- cardiac tissue engineering and regenerative medicine; and
- second opinions before major heart surgery.
Coronary Artery Bypass Surgery
Coronary artery bypass grafting, commonly called CABG, creates new routes for blood to flow around severely narrowed or blocked coronary arteries. It may be considered for selected patients with left main disease, complex multivessel disease, diabetes, reduced heart function, or anatomy less suitable for catheter-based treatment.
The choice between bypass surgery, coronary intervention, and medical treatment depends on symptoms, coronary anatomy, heart function, diabetes, surgical risk, previous procedures, and patient preference. Multidisciplinary discussion between cardiac surgeons and interventional cardiologists can be particularly useful in complex cases.
Surgical planning may involve the use of internal thoracic arteries, radial arteries, or vein grafts. The most appropriate strategy varies with age, anatomy, vessel quality, and long-term risk.
Complex Adult Cardiac Surgery
Patients referred for complex cardiac surgery may have several conditions at the same time, such as coronary disease combined with valve disease, aortic pathology, reduced ventricular function, or previous heart surgery.
Evaluation should consider not only whether an operation is technically possible, but also expected survival, symptom relief, neurological and kidney risk, recovery, rehabilitation, and quality of life.
Repeat operations and combined procedures require careful review of original operative notes, coronary angiography, echocardiography, CT imaging, and current organ function.
Heart Failure and Ischemic Cardiomyopathy
Heart failure can develop when coronary disease damages the heart muscle and reduces its pumping ability. Some patients may benefit from revascularization, valve treatment, rhythm therapy, mechanical support, transplantation assessment, or optimized medical treatment.
Determining whether weakened heart muscle is still viable can help guide revascularization decisions. Testing may include cardiac MRI, PET imaging, stress imaging, echocardiography, and coronary angiography.
Surgery is not appropriate for every patient with severe ventricular dysfunction. The potential benefit must be balanced against perioperative risk and alternative treatments.
Myocardial Protection
Myocardial protection refers to techniques used to protect the heart muscle during cardiac surgery. These may include temperature control, specialized solutions, careful management of blood flow, and strategies that reduce ischemic injury.
Professor Hu’s research has examined mechanisms of heart injury and recovery, with the goal of improving surgical outcomes and preserving ventricular function.
Cardiac Regeneration and Tissue Engineering
Professor Hu has led research into tissue-engineered cardiac patches, stem-cell biology, and regenerative approaches after myocardial injury. Representative work includes preclinical research using human cardiac-muscle patches in large-animal models of heart attack.
This research is scientifically important but should not be interpreted as established routine treatment for heart failure. Regenerative therapies require rigorous clinical trials, regulatory approval, manufacturing controls, and long-term safety evaluation.
Patients should be cautious about clinics marketing unproven stem-cell treatment as a guaranteed alternative to evidence-based cardiac care.
National Cardiovascular Research
Professor Hu has contributed to major programs examining cardiovascular disease burden, surgical outcomes, and quality of care in China. Large-scale registries can identify treatment gaps and help hospitals improve performance.
Population research informs clinical policy, but an individual treatment decision still depends on the patient’s anatomy, symptoms, medical history, and preferences.
Who May Consider a Consultation?
A consultation with Professor Hu or the Fuwai cardiovascular surgery team may be worth considering when a patient:
- has left main or complex multivessel coronary disease;
- has been advised to consider coronary bypass surgery;
- needs a second opinion comparing bypass surgery and coronary stenting;
- has coronary disease with reduced heart function;
- requires a combined coronary and valve procedure;
- has undergone previous cardiac surgery and may need reoperation;
- has received conflicting recommendations about surgical risk; or
- needs multidisciplinary review for advanced ischemic heart disease.
Cardiac Emergencies
New chest pressure, severe shortness of breath, sweating, fainting, or pain spreading to the arm, back, neck, or jaw requires immediate local emergency care. International travel must not delay treatment for a suspected heart attack or unstable cardiac condition.
Medical Records to Prepare
International patients should prepare:
- a concise medical summary and symptom timeline;
- coronary angiography in original DICOM format;
- coronary CT, cardiac MRI, PET, or stress-imaging studies when available;
- recent echocardiography with ventricular and valve measurements;
- electrocardiograms and rhythm-monitoring records;
- operative notes from previous heart or vascular surgery;
- records of previous stents, including vessel, date, and device details;
- recent blood count, kidney and liver function, coagulation, and cardiac biomarkers;
- a complete medication list, especially antiplatelet and anticoagulant drugs; and
- a clear list of questions about surgery, alternatives, risks, and recovery.
Original angiography is essential because written reports alone may not provide enough information to compare bypass surgery with other options.
Planning an International Consultation
Stable patients seeking a second opinion should confirm whether records and imaging can be reviewed, whether an in-person examination is required, and whether additional testing is needed before a surgical decision.
Remote medical-record review is subject to physician authorization. Final treatment eligibility, operative approach, expected hospital stay, and cost require complete assessment by the treating team.
How CMCS Can Assist
CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating cardiac records and imaging, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.
Access to Professor Hu, remote review, surgery, research programs, or any particular treatment is subject to the doctor’s and hospital’s approval. CMCS does not guarantee appointments, treatment eligibility, or clinical outcomes.
For assistance, contact CMCS:
- Email: contract@medicalsh.com
- WhatsApp: Contact us on WhatsApp
- Website: www.medicalsh.com
Important Note
Doctor titles, clinical roles, research activities, procedure availability, and appointment arrangements may change. Patients should confirm current information before travel. This profile is based on publicly available hospital and academic sources and is provided for general information only. It is not individual medical advice and does not replace assessment by a qualified cardiovascular surgeon.
0 則留言